LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

LLY

902.74

-0.9%↓

UNH

596.8

+0.31%↑

NVO

131.05

+0.18%↑

JNJ

164.37

-0.29%↓

ABBV

193.18

+0.34%↑

Home・Stock List・Edwards Lifesciences Corp

Edwards Lifesciences Corp

Closed

Sector Healthcare

66.76 1.26

Buy Sell

Overview

Share price change

24h

Current

Min

66.52

Max

67.02

Key metrics
By Trading Economics
Income	14M 366M
Sales	30M 1.6B
P/E Sector Avg	39.81 103.001
EPS	0.7
Profit margin	22.472
Employees	19,800
EBITDA	-59M 417M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+22.08 upside

Dividends
By Dow Jones
Next Earnings	23 Oct 2024

Market Stats
By TradingEconomics
Market Cap	-289M 42B
Previous open	65.5
Previous close	66.76

News Sentiment

By Acuity

56%

44%

287 / 365 Healthcare

Technical Score

By Trading Central

Confidence

Very Strong Bearish Evidence

64.7 / 68.66 Support & Resistance

Edwards Lifesciences Corp Chart

Related News

15 Jul 2024, 13:57 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences to Buy Innovalve for $300 Million

3 Sept 2024, 20:38 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3 Sept 2024, 20:37 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3 Sept 2024, 20:36 UTC

Acquisitions, Mergers, Takeovers

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25 Jul 2024, 09:02 UTC

Earnings

Hot Stocks

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25 Jul 2024, 08:40 UTC

Peer Comparison

Price change

Edwards Lifesciences Corp Forecast

Price Target

By TipRanks

22.08% upside

12 Months Forecast

Average 80.6 USD 22.08%

High 91 USD

Low 70 USD

Based on 23 Wall Street analysts offering 12 month price targets forEdwards Lifesciences Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

23 ratings

Buy

Hold

Sell

Based on 23 analysts giving stock ratings to Edwards Lifesciences Corp - Dist in the past 3 months.

Technical Score

By Trading Central

64.7 / 68.66Support & Resistance

Recent bearish events outweigh bullish events.

The bullish and bearish events are balanced.

All events are bearish.

Sentiment

By Acuity

287 / 365 Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

EBITDA

Operating profit

About Edwards Lifesciences Corp

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan and Rest of World. Its products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement, Transcatheter Mitral and Tricuspid Therapies, Surgical Structural Heart and Critical Care. It also develops hemodynamic monitoring systems that are used to measure a patient's cardiovascular function in the hospital setting. The Edwards SAPIEN family of valves, including Edwards SAPIEN XT, the Edwards SAPIEN 3, and the Edwards SAPIEN 3 Ultra transcatheter aortic heart valves are used to treat heart valve disease. Its Critical Care products are manufactured in its facilities located in Puerto Rico and the Dominican Republic.